AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2014-11-24 xyj2014

我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？

464 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-02-24 1891e9713cm

想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关

186 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-11-14 ms3000001388865590

审稿速度:1.0 | 投稿命中率:25.0
经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀

42 0

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-19 oncology2005

偏重的研究方向：肿瘤临床
经验分享：一周后，变为with editor，希望别被拒。

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-01-24 亮亮1954

这本杂志接收Meta分析吗，有经验的战友分享下经验。

301 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-10-20 阿雨菇凉

偏重的研究方向：肿瘤;SEER
经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2012-06-28 匿名用户

不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。

540 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2014-07-31 citron521

审稿速度:1.0 | 投稿命中率:75.0
经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。
特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。
只要文章质量入了编辑法眼，很快接受。。。
再改点语法，但是正式上线出版至少得等一年。。。

总结：接受／拒绝快，正式刊出慢

519 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

引言和讨论如何写的不重复？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=507853, encodeId=204d50e853ac, content=我文章从2013年4月份就可以在线查到了，但正式出版期卷页码还没出来，怎么这么慢啊？那如果是2015年才出版，那出版年份是不是就算2015年的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a761606706, createdName=xyj2014, createdTime=Mon Nov 24 00:13:00 CST 2014, time=2014-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585297, encodeId=733c58529eb0, content=想问一下各位大佬，今天投了一篇文章，状态是submitted to journal，然后view QC results里面的figures出现AQC Error，其他都是N/A状态，是怎么回事？需要处理吗？文章目前的状态是不是跟View QC results有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100501, encodeId=ddf021005014e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：不知道为什么他家的网站总是进不去，莫名其妙就是服务器超时，有没有遇到同样问题的小伙伴呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd3c6528589, createdName=ms3000001388865590, createdTime=Mon Nov 14 20:56:01 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220954, encodeId=6b0e1220954e5, content=偏重的研究方向：肿瘤临床 经验分享：一周后，变为with editor，希望别被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Thu May 19 15:50:16 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565972, encodeId=4acf5659e269, content=这本杂志接收Meta分析吗，有经验的战友分享下经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2e81665480, createdName=亮亮1954, createdTime=Thu Jan 24 09:47:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062377, encodeId=16ab10623e7da, content=偏重的研究方向：肿瘤;SEER 经验分享：10.4 帮师姐投了一篇生信，10.8拒搞，推荐两篇转投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/dcd31c69c5ed46ce8d8e6442e9e45be7/8e02a8d7934e4c85b052bde0efecfb37.jpg, createdBy=e1a35466197, createdName=阿雨菇凉, createdTime=Wed Oct 20 20:59:03 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489158, encodeId=a0bf48915861, content=不好投，特别是偏基础的文章，投了2篇均被拒，但是拒稿很快（7-10天），基础研究最好不要尝试（个人意见）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=540, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 28 11:00:00 CST 2012, time=2012-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504783, encodeId=1999504e8385, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：这个杂志偏重临床，基础试验的同学们就尽量避免吧。 特别喜欢接受临床实验的文章，但是设计要合理，对样本量分析等有要求。。。 只要文章质量入了编辑法眼，很快接受。。。 再改点语法，但是正式上线出版至少得等一年。。。 总结：接受／拒绝快，正式刊出慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=196f106245, createdName=citron521, createdTime=Thu Jul 31 03:24:00 CST 2014, time=2014-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086415, encodeId=8446108641503, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086416, encodeId=6de310864167f, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 小动量

和讨论比，引言撰写的方式有什么不同？

50 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务